日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD

探讨MOGAD患儿中心静脉征和顺磁性环状病变的发生频率和预后

Nistri, Riccardo; Cacciaguerra, Laura; Sacco, Simone; Virupakshaiah, Akash; De Meo, Ermelinda; Papinutto, Nico; Henry, Roland G; Meirson, Hadas; Hemingway, Cheryl; Rossor, Thomas; Wassmer, Evangeline; Bensira, Liat; Pratt, Li-Tal; Biswas, Asthik; Sudhakar, Sniya; Mankad, Kshitij; Chen, John J; Pittock, Sean J; Barkhof, Frederik; Ciccarelli, Olga; Waubant, Emmanuelle; Flanagan, Eoin P; Hacohen, Yael

In reply: Why selinexor remains a subpar option?

回复:为什么赛利尼索仍然不是最佳选择?

Mohyuddin, Ghulam Rehman; Meirson, Tomer

Representation of the Middle East and North African Region in Oncology Clinical Trials

中东和北非地区在肿瘤临床试验中的代表性

Taha, Tarek; Meirson, Tomer; Waldhorn, Ithai

IRS2 as a driver of brain metastasis in colorectal cancer: A potential target for novel therapeutic strategies.

IRS2 作为结直肠癌脑转移的驱动因素:一种潜在的新型治疗策略靶点

Greenberg Inbal, Khair-Dabour Fayhaa, Merenbakh-Lamin Keren, Sokol Ethan S, Goldberg Anat Klein, Simkin Dor, Spitzer Avishay, Benhamou Moshe, Bar-Shira Shai, Raz Michal, Grossman Rachel, Yeini Eilam, Ofek Paula, Meirson Tomer, Satchi-Fainaro Ronit, Reuveni Hadas, Wolf Ido, Rubinek Tami

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring

利用差异性删失数据重新分析尿路上皮癌化疗免疫疗法试验

Meirson, Tomer; Ofer, Jonathan; Zimhony-Nissim, Noa; Bareket-Samish, Avital; Markel, Gal; Neiman, Victoria; Cherny, Nathan; Goldstein, Daniel A; Gyawali, Bishal; Tannock, Ian; Rosenbaum, Eli

Survival-inferred fragility of statistical significance in phase III oncology trials

III期肿瘤试验中基于生存推断的统计学意义脆弱性

Sherry, Alexander D; Liu, Yufei; Msaouel, Pavlos; Lin, Timothy A; Koong, Alex; Lin, Christine; Abi Jaoude, Joseph; Patel, Roshal R; Kouzy, Ramez; El-Alam, Molly B; Miller, Avital M; Owiwi, Mohannad; Ofer, Jonathan; Bomze, David; McCaw, Zachary R; Meirson, Tomer; Ludmir, Ethan B

Spectrum of Clinical and Imaging Features of Children With GFAP Astrocytopathy

GFAP星形胶质细胞病患儿的临床和影像学特征谱

Sommer, Simon; Panzer, Andreas; Bertolini, Annikki; Cleaveland, Robert; Jain, Vivek; Kapanci, Tugba; Derichs, Ute; Geis, Tobias; Neu, Axel; Löhr-Nilles, Christa; Aeschimann-Huhn, Rahel; Flotats-Bastardas, Marina; Deiva, Kumaran; Armangue, Thais; Olivé-Cirera, Gemma; Kannoth, Sudheeran; Koy, Anne; Meirson, Hadas; Fattal-Valevski, Aviva; Ganelin-Cohen, Esther; Losch, Heike; Horne, Annacarin; Wickström, Ronny; Dargvainiene, Justina; Leypoldt, Frank; Rostasy, Kevin

Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis

具有统计学意义的III期肿瘤临床试验的可重复性:一项计算机模拟荟萃流行病学分析

Sherry, Alexander D; Msaouel, Pavlos; Miller, Avital M; Lin, Timothy A; Abi Jaoude, Joseph; Kouzy, Ramez; Passy, Adina H; Meirson, Tomer; Ignatiadis, Nikolaos; McCaw, Zachary R; van Zwet, Erik; Ludmir, Ethan B

Bayesian interim analysis and efficiency of phase III randomized trials

贝叶斯中期分析和 III 期随机试验的效率

Sherry, Alexander D; Msaouel, Pavlos; Miller, Avital M; Lin, Timothy A; Kupferman, Gabrielle S; Abi Jaoude, Joseph; Kouzy, Ramez; El-Alam, Molly B; Patel, Roshal; Koong, Alex; Lin, Christine; Meirson, Tomer; McCaw, Zachary R; Ludmir, Ethan B

How the addition of selinexor/bortezomib/dexamethasone as a Category 1 recommendation may erode outcomes

将塞利尼索/硼替佐米/地塞米松作为一级推荐方案加入治疗方案可能会如何削弱疗效

Chahine, Zena; Meirson, Tomer; Gilboa, Shai; Mohyuddin, Ghulam Rehman